Keyphrases
Oxidative Stress
100%
Pancreatic β-cell Function
100%
Rilpivirine
100%
Divergent Effects
100%
Survival Chances
100%
Mitochondrial Dysfunction
100%
HIV-1 Reverse Transcriptase
100%
Efavirenz
83%
Type 2 Diabetes Mellitus (T2DM)
50%
Reverse Transcriptase Inhibitors
50%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
50%
Nucleosides
50%
INS-1E Cells
50%
Cell Viability
33%
Insulin
33%
Damaging Effects
33%
Type 2 Diabetic
33%
Emtricitabine
33%
β-Cell Survival
33%
β-cell Function
33%
Tenofovir Disoproxil Fumarate
33%
Doravirine
33%
B Cells
16%
Protein Expression
16%
MRNA Expression
16%
Induced Apoptosis
16%
Contrast Effect
16%
Antiretroviral Therapy
16%
Treatment Strategy
16%
Molecular Mechanism
16%
Deleterious Effects
16%
AIDS/HIV
16%
Cellular Mechanisms
16%
Life-sustaining Treatment
16%
Cell Apoptosis
16%
In Silico Docking
16%
Insulin Release
16%
ROS Generation
16%
Insulinoma
16%
Apoptosis-necrosis
16%
Oxidative Stress Toxicity
16%
Glucose-regulated Protein 78 (GRP78)
16%
HIV Patients
16%
Mitochondrial ATP Synthase
16%
Type 2 Diabetes Mellitus Risk
16%
Endoplasmic Reticulum Stress (ER stress)
16%
Mitochondrial Toxicity
16%
Medicine and Dentistry
Beta Cell
100%
Oxidative Stress
100%
Cell Function
100%
Cell Survival
100%
RNA Directed DNA Polymerase
100%
Rilpivirine
100%
Reverse-Transcriptase Inhibitor
100%
Efavirenz
83%
Maturity Onset Diabetes of the Young
66%
Nonnucleoside Reverse Transcriptase Inhibitor
50%
Nucleoside
50%
Cell Viability
33%
Programmed Cell Death
33%
Diabetes Mellitus
33%
Emtricitabine
33%
Tenofovir Disoproxil
33%
Doravirine
33%
Protein Expression
16%
Synthetase
16%
Human Immunodeficiency Virus
16%
Antiretroviral Therapy
16%
Reactive Oxygen Species
16%
Necrosis
16%
Adenosine Triphosphate
16%
Insulin Release
16%
In Silico
16%
HIV/AIDS
16%
CHOP
16%
Nesidioblastosis
16%
Cell Membrane Potential
16%
Endoplasmic Reticulum Stress
16%
Mitochondrial Toxicity
16%
Pharmacology, Toxicology and Pharmaceutical Science
RNA Directed DNA Polymerase Inhibitor
100%
Rilpivirine
100%
RNA Directed DNA Polymerase
100%
Efavirenz
83%
Non Insulin Dependent Diabetes Mellitus
66%
Nonnucleoside Reverse Transcriptase Inhibitor
50%
Nucleoside
50%
HIV
33%
Diabetes Mellitus
33%
Cell Viability
33%
Emtricitabine
33%
Doravirine
33%
Tenofovir Disoproxil
33%
Necrosis
16%
Synthetase
16%
Adenosine Triphosphate
16%
Insulinoma
16%
Mitochondrial Toxicity
16%